Trial Profile
A prospective, multi-centric, open-label, single arm study to evaluate the safety and efficacy of 4mg of ZYH1 in hypertriglyceridemia in HIV associated lipodystrophy - NA
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Jul 2019
Price :
$35
*
At a glance
- Drugs Saroglitazar (Primary)
- Indications HIV-associated lipodystrophy syndrome; Hypertriglyceridaemia
- Focus Therapeutic Use
- Acronyms PRESS VII
- Sponsors Cadila Healthcare
- 17 Sep 2010 New trial record